欧林生物涨2.04%，成交额5796.67万元，主力资金净流入505.54万元

Core Viewpoint - Oulin Biotech has shown significant stock performance with a year-to-date increase of 169.43%, despite a recent slight decline in the last five trading days [1] Group 1: Stock Performance - As of September 9, Oulin Biotech's stock price reached 28.56 CNY per share, with a market capitalization of 11.593 billion CNY [1] - The stock has experienced a 1.07% decline over the last five trading days, but a 39.32% increase over the last 20 days and a 76.62% increase over the last 60 days [1] - The company has appeared on the "龙虎榜" (top trading list) twice this year, with the latest occurrence on August 20 [1] Group 2: Financial Performance - For the first half of 2025, Oulin Biotech reported a revenue of 306 million CNY, representing a year-on-year growth of 35.17% [2] - The net profit attributable to shareholders for the same period was 13.197 million CNY, showing a substantial increase of 147.22% year-on-year [2] Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders increased by 4.86% to 6,521, while the average number of circulating shares per person decreased by 4.63% to 62,169 shares [2] - The company has distributed a total of 15.434 million CNY in dividends since its A-share listing [3] - Among the top ten circulating shareholders, "兴全合润混合A" holds 15.4402 million shares, while "兴全合宜混合A" holds 8.9214 million shares, with both maintaining their holdings from the previous period [3]